Diagnostic prediction of complex diseases using phase-only correlation based on virtual sample template

Motivation: Complex diseases induce perturbations to interaction and regulation networks in living systems, resulting in dynamic equilibrium states that differ for different diseases and also normal states. Thus identifying gene expression patterns corresponding to different equilibrium states is of great benefit to the diagnosis and treatment of complex diseases. However, it remains a major challenge to deal with the high dimensionality and small size of available complex disease gene expression datasets currently used for discovering gene expression patterns. Results: Here we present a phase-only correlation (POC) based classification method for recognizing the type of complex diseases. First, a virtual sample template is constructed for each subclass by averaging all samples of each subclass in a training dataset. Then the label of a test sample is determined by measuring the similarity between the test sample and each template. This novel method can detect the similarity of overall patterns emerged from the differentially expressed genes or proteins while ignoring small mismatches. Conclusions: The experimental results obtained on seven publicly available complex disease datasets including microarray and protein array data demonstrate that the proposed POC-based disease classification method is effective and robust for diagnosing complex diseases with regard to the number of initially selected features, and its recognition accuracy is better than or comparable to other state-of-the-art machine learning methods. In addition, the proposed method does not require parameter tuning and data scaling, which can effectively reduce the occurrence of over-fitting and bias

Cardiac Computed Tomography Radiomics: A Comprehensive Review on Radiomic Techniques

Radiologic images are vast three-dimensional data sets in which each voxel of the underlying volume represents distinct physical measurements of a tissue-dependent characteristic. Advances in technology allow radiologists to image pathologies with unforeseen detail, thereby further increasing the amount of information to be processed. Even though the imaging modalities have advanced greatly, our interpretation of the images has remained essentially unchanged for decades. We have arrived in the era of precision medicine where even slight differences in disease manifestation are seen as potential target points for new intervention strategies. There is a pressing need to improve and expand the interpretation of radiologic images if we wish to keep up with the progress in other diagnostic areas. Radiomics is the process of extracting numerous quantitative features from a given region of interest to create large data sets in which each abnormality is described by hundreds of parameters. From these parameters datamining is used to explore and establish new, meaningful correlations between the variables and the clinical data. Predictive models can be built on the basis of the results, which may broaden our knowledge of diseases and assist clinical decision making. Radiomics is a complex subject that involves the interaction of different disciplines; our objective is to explain commonly used radiomic techniques and review current applications in cardiac computed tomography imaging.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/

Applying Deep Learning To Identify Imaging Biomarkers To Predict Cardiac Outcomes In Cancer Patients

Cancer patients are a unique population with increased mortality from cardiovascular disease, however only half of high-risk patients are medically optimized. Physicians ascertain cardiovascular risk from several risk predictors using demographic information, family history, and imaging data. The Agatston score, a measure of total calcium burden in coronary arteries on CT scans, is the current best predictor for major adverse cardiac events (MACE). Yet, the score is limited as it does not provide information on atherosclerotic plaque characteristics or distribution. In this study, we use deep learning techniques to develop an imaging-based biomarker that can robustly predict MACE in lung cancer patients. We selected participants with screen-detected lung cancer from the National Lung Screening Trial (NLST) and used cardiovascular mortality as our primary outcome. We applied automated segmentation algorithms to low-dose chest CT scans from NLST participants to segment cardiac substructures. Following segmentation, we extracted radiomic features from selected cardiac structures. We then used this dataset to train a regression model to predict cardiovascular death. We used a pre-trained nnU-Net model to successfully segment large cardiac structures on CT scans. These automated large cardiac structures had features that were predictive of MACE. We then successfully extract radiomic features from our areas of interest and use this high-dimensional dataset to train a regression model to predict MACE. We demonstrated that automated segmentation algorithms can result in low-cost non-invasive predictive biomarkers for MACE. We were able to demonstrate that radiomic feature extraction from segmented substructures can be used to develop a high-dimensional biomarker. We hope that such a scoring system can help physicians adequately determine cardiovascular risk and intervene, resulting in better patient outcomes

Interleukin-1β inhibition for chronic kidney disease in obese mice with type 2 diabetes

An animal model with overt DKD is needed for preclinical study. Uninephrectomy is a common tool to accelerate kidney impairment but it has shortcomings such as lethality and kidney infection. Given that oxalate-rich diet is a convenient method to generate progressive nephrocalcinosis, tubular atrophy, and CKD in C56BL6 mice, we want to explore the possibility of using oxalate-rich diet as a substitutive and non-surgical approach to accelerate kidney impairment in db/db. We fed db/db mice of 14 weeks old with oxalate-rich diet or control diet for 30 days. We measured GFR every 10 days and analysed the crystal deposition in kidney after 30 days. We found that oxalate rich diet did not induce GFR loss and oxalate crystal deposition in kidney compared to mice with control diet. Inflammation is one of the center mechanisms leading to DKD. Infiltrated immune cells as well as renal resident cells release various cytokines which contribute to kidney function loss and structural alterations. Of the cytokines, IL-1β is a key mediator in amplifying inflammation, such as upregulating chemokines and other cytokines. IL-1β also contributes to kidney fibrosis. Thus IL-1β serves as a potential target for DKD. Previous studies have shown that NLRP3-dependent IL-1β from non-myeloid cell contribute to initiation and progression of DKD in diabetic mice, even though other studies suggested that non-myeloid cells may lack the ability to synthesis IL-1β. Our first aim was to investigate IL-1β expression and possible cellular location in kidney. We observed IL-1β expression was mildly increased in kidney biopsies from patients with diabetes at protein and mRNA level, as indicated by immunostaining and microarray, respectively. In a uninephrectomized db/db mice, IL-1β gene expression level was also increased. Furthermore, human biopsy immunostainings demonstrated that IL-1β was mainly located in infiltrated immune cells. Therefore, IL-1β expression was induced in DKD and was mainly expressed by immune cells. Since we observed IL-1β expression is increased in DKD, we hypothesized that targeting IL-1β has a renal protective effect on DKD in animal model of DKD. To test this hypothesis, we treated 18-week-old db/db mice undergoing uninephrectomy at the age of 8 weeks with anti-IL-1β IgG antibody or control IgG for 8 weeks. Mice treated with anti-IL-1β IgG preserved higher glomerular filtration rate but comparable albuminuria level to those treated with control IgG. On glomerular structural changes, anti-IL-1β antibody treatment did not affect glomerular tuft and Bowman’s capsule size, nor collagen deposition in glomeruli. However, anti-IL-1β showed higher podocyte account and higher expression levels of podocyte marker genes. IL-1β blockade also reduced infiltrated macrophages in glomeruli. On fibrosis, IL-1β blockade did not reduced alpha smooth muscle actin accumulation, but reduced fibrosis gene expression, such as Acta2 and Col4a3. In conclusion, (i) oxalate-rich diet did not induce massive oxalate crystal deposition in kidney nor GFR loss, thus is not a suitable method to generate overt DKD in db/db model. (ii) kidney IL-1β expression mildly increased in human diabetes, and mainly originated from immune cells. Targeting IL-1β by antibody generated a moderate effect on glomerular filtration rate decline, podocyte loss, and renal inflammation in type 2 diabetic mice with CKD. Whether these findings can translate into better outcomes also in human DKD remains to be determined

Deep Functional Mapping For Predicting Cancer Outcome

The effective understanding of the biological behavior and prognosis of cancer subtypes is becoming very important in-patient administration. Cancer is a diverse disorder in which a significant medical progression and diagnosis for each subtype can be observed and characterized. Computer-aided diagnosis for early detection and diagnosis of many kinds of diseases has evolved in the last decade. In this research, we address challenges associated with multi-organ disease diagnosis and recommend numerous models for enhanced analysis. We concentrate on evaluating the Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) for brain, lung, and breast scans to detect, segment, and classify types of cancer from biomedical images. Moreover, histopathological, and genomic classification of cancer prognosis has been considered for multi-organ disease diagnosis and biomarker recommendation. We considered multi-modal, multi-class classification during this study. We are proposing implementing deep learning techniques based on Convolutional Neural Network and Generative Adversarial Network. In our proposed research we plan to demonstrate ways to increase the performance of the disease diagnosis by focusing on a combined diagnosis of histology, image processing, and genomics. It has been observed that the combination of medical imaging and gene expression can effectively handle the cancer detection situation with a higher diagnostic rate rather than considering the individual disease diagnosis. This research puts forward a blockchain-based system that facilitates interpretations and enhancements pertaining to automated biomedical systems. In this scheme, a secured sharing of the biomedical images and gene expression has been established. To maintain the secured sharing of the biomedical contents in a distributed system or among the hospitals, a blockchain-based algorithm is considered that generates a secure sequence to identity a hash key. This adaptive feature enables the algorithm to use multiple data types and combines various biomedical images and text records. All data related to patients, including identity, pathological records are encrypted using private key cryptography based on blockchain architecture to maintain data privacy and secure sharing of the biomedical contents

Radiomics and Machine Learning in the Prediction of Cardiovascular Disease

Carotid atherosclerosis is a major risk factor for ischaemic stroke which is a leading cause of death worldwide. For stroke survivors, 1 in 4 will have another stroke within five years. Carotid CT angiography (CTA) is commonly performed following an ischaemic stroke or transient ischemic attack to help guide patient management in the secondary prevention of stroke. For example, carotid endarterectomy surgery plus medical therapy or medical therapy alone. The degree of carotid stenosis is the mainstay in making this decision and uses only one aspect of anatomical information that can be obtained from a carotid CTA scan. Radiomics, sometimes called ‘texture analysis’, is the extraction of quantitative data from medical images that may not be apparent to the naked eye and has already demonstrated clinical utility in oncology for applications ranging from lesion characterisation to tumour grading and prognostication. Machine learning refers to the process of learning from experience (in this case data), rather than following pre-programmed rules. This thesis presents the findings of a proof-of-principle study to assess the value of radiomics in identifying the ‘vulnerable plaque’ and the ‘vulnerable patient’ within the context of cerebrovascular events. To evaluate the potential of radiomic features as imaging biomarkers, their reproducibility and robustness to morphological perturbations were assessed, as well as their biological associations with both PET and immunohistochemistry data. The ability of radiomic features to classify different carotid artery types, namely, culprit, non-culprit and asymptomatic carotid arteries was assessed using several machine learning classifiers. This was subsequently compared with a deep learning approach, which has greater capacity for data mining than feature-based machine learning approaches. Overall, radiomics could extract further useful information from carotid CTA scans. Culprit versus non-culprit carotid arteries in symptomatic patients and asymptomatic carotid arteries from asymptomatic patients had different radiomic profiles that could be leveraged using machine learning for better classification performance than carotid calcification or carotid PET imaging alone. Reliable and robust CT-based carotid radiomic features were identified that were associated with the degree of inflammation underlying the carotid artery. If validated with future prospective studies, this has the potential to improve personalised patient care in stroke management and advance clinical decision-making.Cambridge School of Clinical Medicine, the Medical Research Council's Doctoral Training Partnership and the Frank Edward Elmore Fun

Non-communicable Diseases, Big Data and Artificial Intelligence

This reprint includes 15 articles in the field of non-communicable Diseases, big data, and artificial intelligence, overviewing the most recent advances in the field of AI and their application potential in 3P medicine

Neuropathy Classification of Corneal Nerve Images Using Artificial Intelligence

Nerve variations in the human cornea have been associated with alterations in the neuropathy state of a patient suffering from chronic diseases. For some diseases, such as diabetes, detection of neuropathy prior to visible symptoms is important, whereas for others, such as multiple sclerosis, early prediction of disease worsening is crucial. As current methods fail to provide early diagnosis of neuropathy, in vivo corneal confocal microscopy enables very early insight into the nerve damage by illuminating and magnifying the human cornea. This non-invasive method captures a sequence of images from the corneal sub-basal nerve plexus. Current practices of manual nerve tracing and classification impede the advancement of medical research in this domain. Since corneal nerve analysis for neuropathy is in its initial stages, there is a dire need for process automation. To address this limitation, we seek to automate the two stages of this process: nerve segmentation and neuropathy classification of images. For nerve segmentation, we compare the performance of two existing solutions on multiple datasets to select the appropriate method and proceed to the classification stage. Consequently, we approach neuropathy classification of the images through artificial intelligence using Adaptive Neuro-Fuzzy Inference System, Support Vector Machines, Naïve Bayes and k-nearest neighbors. We further compare the performance of machine learning classifiers with deep learning. We ascertained that nerve segmentation using convolutional neural networks provided a significant improvement in sensitivity and false negative rate by at least 5% over the state-of-the-art software. For classification, ANFIS yielded the best classification accuracy of 93.7% compared to other classifiers. Furthermore, for this problem, machine learning approaches performed better in terms of classification accuracy than deep learning

Computational pan-genomics: status, promises and challenges

International audienceMany disciplines, from human genetics and oncology to plant breeding, microbiology and virology, commonly face the challenge of analyzing rapidly increasing numbers of genomes. In case of Homo sapiens, the number of sequenced genomes will approach hundreds of thousands in the next few years. Simply scaling up established bioinformatics pipelines will not be sufficient for leveraging the full potential of such rich genomic data sets. Instead, novel, qualitatively different computational methods and paradigms are needed. We will witness the rapid extension of computational pan-genomics, a new sub-area of research in computational biology. In this article, we generalize existing definitions and understand a pan-genome as any collection of genomic sequences to be analyzed jointly or to be used as a reference. We examine already available approaches to construct and use pan-genomes, discuss the potential benefits of future technologies and methodologies and review open challenges from the vantage point of the above-mentioned biological disciplines. As a prominent example for a computational paradigm shift, we particularly highlight the transition from the representation of reference genomes as strings to representations as graphs. We outline how this and other challenges from different application domains translate into common computational problems, point out relevant bioinformatics techniques and identify open problems in computer science. With this review, we aim to increase awareness that a joint approach to computational pan-genomics can help address many of the problems currently faced in various domains